NYU Langone's Perlmutter Cancer Center | Strategic Alliance Partners

August 13, 2020

In our exclusive interview, Marc J. Braunstein, MD, PhD, provides perspective on data in the upfront and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.

August 06, 2020

Vamsidhar Velcheti, MD, discusses the current and emerging treatment options for patients with ALK- and ROS1-positive non–small cell lung cancer.

August 04, 2020

Elaine Shum, MD, discusses consulting patients with non-small cell lung cancer on the use of osimertinib.

June 15, 2020

Shella Saint Fleur-Lominy, MD, PhD, discusses targeted pathways in myeloproliferative neoplasms.

June 06, 2020

Mohammad Maher Abdul-Hay, MD, discusses the use of the Hematopoietic Cell Transplantation-specific Comorbidity Index (HCT-CI) to guide transplant eligibility in acute lymphoblastic leukemia (ALL).

June 05, 2020

Diane M. Simeone, MD, discusses the importance of germline testing in pancreatic cancer.

June 03, 2020

Aaron E. Katz, MD, FACS, discusses re-classifying low-risk prostate scores with the 17-gene Oncotype DX Genomic Prostate Score.

June 02, 2020

Aaron E. Katz, MD, FACS, discusses strategies for determining low-risk prostate cancer.

May 22, 2020

Gareth J. Morgan, MD, PhD, provides insight on determining treatment selection for patients with multiple myeloma.

May 21, 2020

Michael L. Grossbard, MD, discusses the role of maintenance rituximab (Rituxan) in follicular lymphoma.

May 20, 2020

Michael L. Grossbard, MD, discusses the role of maintenance rituximab (Rituxan) in follicular lymphoma.

May 13, 2020

Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.

May 12, 2020

Marc J. Braunstein, MD, PhD, discusses updated results from the GRIFFIN trial in multiple myeloma.

May 09, 2020

Marc J. Braunstein, MD, PhD, discusses quadruplet therapies in multiple myeloma.

May 08, 2020

Bruce G. Raphael, MD, discusses the utility of venetoclax and obinutuzumab in chronic lymphocytic leukemia.

May 07, 2020

Diane M. Simeone, MD, discusses the benefit of using a gemcitabine “sandwich approach” in patients with resectable pancreatic cancer.

May 01, 2020

Anna C. Pavlick, DO, discusses updated results from the COLUMBUS trial in metastatic melanoma.

April 28, 2020

Shella Saint Fleur-Lominy, MD, PhD, discusses the current sequencing strategy in the treatment of patients with myeloproliferative neiplasms.

April 24, 2020

Bhavana Pothuri, MD, discusses the importance of obtaining patient-reported outcomes in ovarian cancer.

April 21, 2020

Faith E. Davies, MD, discusses the research being done in patients with multiple myeloma who are refractory to lenalidomide.